Immunoadjuvant effects of bacterial genomic DNA and CpG oligodeoxynucleotides on avian influenza virus subtype H5N1 inactivated oil emulsion vaccine in chicken

Research in Veterinary Science

Volumn 86, Issue 3, 2009, Pages 399-405

  Wang, Yimeng ^a,b,c   Shan, Chunqiao ^b   Ming, Shuangxi ^a   Liu, Yan ^a,b   Du, Yuchun ^c   Jiang, Guotuo ^a,b  

^a DALIAN POLYTECHNIC UNIVERSITY   (China)

^b Dalian Sanyi Animal Medicine Co Ltd   (China)

^c UNIVERSITY OF ARKANSAS   (United States)

Author keywords

Adjuvant; Avian influenza virus subtype H5N1 inactivated oil emulsion vaccine; Bacterial genomic DNA; CpG ODN; Immune responses; Immunization approaches

Indexed keywords

CPG OLIGODEOXYNUCLEOTIDE; GAMMA INTERFERON; GENOMIC DNA; IMMUNOGLOBULIN G; IMMUNOLOGICAL ADJUVANT; INFLUENZA VACCINE; INTERLEUKIN 10;

ANIMAL EXPERIMENT; ANTIBODY TITER; ARTICLE; AVIAN INFLUENZA; CELLULAR IMMUNITY; CHICKEN; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DNA EXTRACTION; EMULSION; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; HEMAGGLUTINATION; HUMORAL IMMUNITY; IMMUNIZATION; INFLUENZA VIRUS A H5N1; INHIBITION KINETICS; INOCULATION; NONHUMAN; STAPHYLOCOCCUS AUREUS; TH1 CELL;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODY FORMATION; BACTERIA; BASE SEQUENCE; CHICKENS; DNA, BACTERIAL; EMULSIONS; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; GENES, BACTERIAL; GENOME, BACTERIAL; IMMUNOGLOBULIN G; INFLUENZA A VIRUS; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA IN BIRDS; INTERFERON-GAMMA; INTERLEUKIN-10; OLIGODEOXYRIBONUCLEOTIDES; POULTRY DISEASES; STAPHYLOCOCCUS AUREUS; VIRAL VACCINES;

AVIAN INFLUENZA VIRUS; BACTERIA (MICROORGANISMS); ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; GALLUS GALLUS; STAPHYLOCOCCUS AUREUS;

EID: 64449084544     PISSN: 00345288     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rvsc.2008.09.006     Document Type: Article

References (26)

1. Cho Y.J., Ahn B.Y., Lee N.G., Lee D.H., and Kim D.S. A combination of E. coli DNA fragments and modified lipopolysaccharides as a cancer immunotherapy. Vaccine 24 (2006) 5862-5871
2. Chu R.S., Targoni O.S., Krieg A.M., Lehmann P.V., and Harding C.V. CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity. J. Exp. Med. 186 (1997) 1623-1631
3. Chu R.S., McCool T., Greenspan N.S., Schreiber J.R., and Harding C.V. CpG oligodeoxynucleotides act as adjuvants for pneumococcal polysaccharide-protein conjugate vaccines and enhance antipolysaccharide immunoglobulin G2a (IgG2a) and IgG3 antibodies. Infect. Immun. 68 (2000) 1450-1456
4. Coutelier J.P., van der Logt T.M., Heessen W.A., Vink A., and Van Snick J. Virally induced modulation of murine IgG antibody subclasses. J. Exp. Med. 168 (1988) 2373-2378
5. Coutelier J.P., van der Logt T.M., and Heessen W.A. IgG subclass distribution of primary and secondary immune responses concomitant with viral infection. J. Immunol. 147 (1991) 1383-1386
6. Cowdery J.S., Chace J.H., Yi A.K., and Krieg A.M. Bacterial DNA induces NK cells to produce IFN-gamma in vivo and increases the toxicity of lipopolysaccharides. J. Immunol. 156 (1996) 4570-4575
7. Crawley A., Raymond C., and Wilkie B.N. Control of immunoglobulin isotype production by porcine B-cells cultured with cytokines. Vet. Immunol. Immunopathol. 91 (2003) 141-154
8. de Waal Malefyt R., Abrams J., Bennett B., Figdor C.G., and de Vries J.E. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J. Exp. Med. 174 (1991) 1209-1220
9. Deml L., Schirmbeck R., Reimann J., Wolf H., and Wagner R. Immunostimulatory CpG motifs trigger a T helper-1 immune response to human immunodeficiency virus type-1 (HIV-1) gp 160 envelope proteins. Clin. Chem. Lab. Med. 37 (1999) 199-204
10. Fuchs A.C., Granowitz E.V., Shapiro L., Vannier E., Lonnemann G., Angel J.B., Kennedy J.S., Rabson A.R., Radwanski E., Affrime M.B., Cutler D.L., Grint P.C., and Dinarello C.A. Clinical, hematologic, and immunologic effects of interleukin-10 in humans. J. Clin. Immunol. 16 (1996) 291-303
11. Guo Y.J., Wu D., Wang K.Y., and Sun S.H. Adjuvant effects of bacillus Calmette-Guerin DNA or CpG-oligonucleotide in the immune response to Taenia solium cysticercosis vaccine in porcine. Scand. J. Immunol. 66 (2007) 619-627
12. Halpern M.D., Kurlander R.J., and Pisetsky D.S. Bacterial DNA induces murine interferon-gamma production by stimulation of interleukin-12 and tumor necrosis factor-alpha. Cell Immunol. 167 (1996) 72-78
13. Hemmi H., Takeuchi O., Kawai T., Kaisho T., Sato S., Sanjo H., Matsumoto M., Hoshino K., Wagner H., Takeda K., and Akira S. A toll-like receptor recognizes bacterial DNA. Nature 408 (2000) 740-745
14. Klinman D., Yi A.K., Beaucage S.L., Conover J., and Krieg A.M. CpG motifs expressed by bacterial DNA rapidly induce lymphocytes to secrete IL-6, IL-12 and IFN-g. Proc. Natl. Acad. Sci. USA 93 (1996) 2879-2883
15. Krieg A.M., Yi A.K., Matson S., Waldschmidt T.J., Bishop G.A., Teasdale R., Koretzky G.A., and Klinman D.M. CpG motifs in bacterial DNA trigger direct B cell activation. Nature 374 (1995) 546-549
16. Ligon B.L. Avian influenza virus H5N1: a review of its history and information regarding its potential to cause the next pandemic. Semin. Pediatr. Infect. Dis. 16 (2005) 326-335
17. Linghua Z., Xingshan T., and Fengzhen Z. Vaccination with Newcastle disease vaccine and CpG oligodeoxynucleotides induces specific immunity and protection against Newcastle disease virus in SPF chicken. Vet. Immunol. Immunopathol. 115 (2007) 216-222
18. Linghua Z., Xingshan T., and Fengzhen Z. Intranasal administration of CpG oligonucleotides induces mucosal and systemic Type 1 immune responses and adjuvant activity to porcine reproductive and respiratory syndrome killed virus vaccine in piglets in vivo. Int. Immunopharmacol. 7 (2007) 1732-1740
19. OIE, 2005. Manual of diagnostic tests for Avian influenza. .
20. Ricardo S.C., and Patricia B.P. CpG DNA as a Th1-promoting adjuvant in immunization against Trypanosoma cruzi. Vaccine 19 (2001) 234-242
21. Roman M., Martin-Orozco E., Goodman J.S., Nguyen M.D., Sato Y., Ronaghy A., Kornbluth R.S., Richman D.D., Carson D.A., and Raz E. Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants. Nature 3 (1997) 849-854
22. Tsujimoto H., Ono S., Matsumoto A., Kawabata T., Kinoshita M., Majima1 T., Hiraki S., Seki S., Moldawer L., and Mochizuki H. A critical role of CpG motifs in a murine peritonitis model by their binding to highly expressed toll-like receptor-9 on liver NKT cells. J. Hepatol. 45 (2006) 836-843
23. Vleugels B., Ververken C., and Goddeeris B.M. Stimulatory effect of CpG sequences on humoral response in chickens. Poultry Sci. 81 (2002) 1317-1321
24. Yamada H., Gursel I., Takeshita F., Conover J., Ishii K.J., Gursel M., Takeshita S., and Klinman D.M. Effect of suppressive DNA on CpG-induced immune activation. J. Immunol. 169 (2002) 5590-5594
25. Yimeng W., Sheping G., Yan L., Shuangxi M., and Guotuo J. Vaccination with probiotics genomes DNA and avian influenza virus H5N1 oil vaccine reduces the humoral immunoresponse in chickens (Chinese). China Poultry 24 (2007) 19-22
26. Zhang L., Guo Y., Tian X., and Zhou F. Co-administration of porcine-specific CpG oligodeoxynucleotide enhances the immune responses to pseudorabies attenuated virus vaccine in newborn piglets in vivo. Dev. Comp. Immunol. 30 (2006) 589-596